The effect of curcumin on human B-cell immortalization by Epstein-Barr virus

American Surgeon

Volumn 64, Issue 1, 1998, Pages 47-52

  Ranjan, Dinesh ^a,b   Siquijor, Alex ^a   Johnston, Thomas D ^a   Wu, Gaunghan ^a   Nagabhuskahn, Moolky ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b C453 Transplant Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYCLOSPORIN A; HYDROGEN PEROXIDE;

ARTICLE; B LYMPHOCYTE; CANCER; CELL IMMORTALIZATION; CONTROLLED STUDY; CURCUMA LONGA; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; ORGAN TRANSPLANTATION; OXIDATIVE STRESS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CURCUMIN; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOPROLIFERATIVE DISORDERS; OXIDATIVE STRESS;

EID: 0031984535     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Calne RY. Immunosuppression for organ grafting observations on cyclosporin A. Immunol. Rev. 1979;46:113-24.
2. Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993;12:S328-36.
3. Swerdlow SH. Post-transplant lymphoproliferative disorders: A morphologic, phenotypic, and genotypic spectrum of disease. Histopathology 1991;20:373-85.
4. Rickinson AB, Rowe M, Hart IJ, et al. T-cell mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: Studies with cyclosporin A. Cell. Immunol. 1984;87:646-58.
5. Thorley-Lawson DA. Basic virological aspects of Epstein-Barr virus infection. Semin Hematol 1988;25:247-60.
6. Oya Y, Tonomura A, Yamamoto K. The biological activity of hydrogen peroxide. III. Induction of Epstein-Barr virus via indirect action, as compared with TPA and Teleocidin. Int J Cancer 1987;40:69-73.
7. Maeda H, Katsuki T, Akaike T, Yasutake R. High correlation between lipid peroxide radical and tumor-promoter effect: Suppression of tumor promotion in Epstein-Barr virus/B-lymphocyte system and scavenging of alkyl peroxide radicals by various vegetable extracts. Jpn J Cancer Res 1992;83:923-8.
8. Khader AA, Sulaiman M, Kishore PN, et al. Quinacrine attenuates cyclosporine-induced nephrotoxicity in rats. Transplantation 1996;62:427-35.
9. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int 1995;47:927-34.
10. Kunchandy E, Rao MNA. Oxygen radical scavenging activity of curcumin. Int J Pharm 1990;58:237-40.
11. Ammon HPT, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 1993;38:113-9.
12. Nagabhushan M, Bhide SV. Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992;11:192-8.
13. Rao VR, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon cancer by dietary curcumin. Ann NY Acad Sci 1995;768: 201-4.
14. Srivastava R. Inhibition of neutrophil response by curcumin. Agents Actions 1989;28:298-303.
15. Moss DJ, Pope JH. Assay of infectivity of Epstein-Barr virus by transformation of human leukocytes in vitro. J Gen Virol 1972;17:233-6.
16. Menzes J, Leibold W, Klein G. Biological differences between Epstein-Barr Virus (EBV) strains with regard to lymphocyte transforming ability, superinfection, and antigen induction. Exp Cell Res 1975;92:478-84.
17. Nagabhushan M. Mutagens and antimutagens from Indian diet with special reference to spices. In: Department of Biochemistry. Bombay, India: University of Bombay, 1987, p 308.
18. Henderson E. Physicochemical-viral synergism during Epstein-Barr virus infection: A review. J Natl Cancer Inst 1988;80:476-83.
19. Middleton T, Gahn TA, Martin JM, Sugden B. Immortalizing genes of Epstein-Barr virus. Adv Virus Res 1991;40:19-49.
20. Tanner JE, Alfieri C, Chatila TA, Diaz-Mitoma F. Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220. J Virol 1996;70:570-5.
21. Rowe M, Peng-Pilon M, Huen DS, Hardy R, et al. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: A B-cell-specific response that is delayed relative to NF-KB activation and to induction of cell surface markers. J Virol 1994;68:5602-12.
22. Bonvier G, Hergenhahn M, Polack A, et al. Validation of two test systems for detecting tumor promoters and EBV inducers: Comparative responses of several agents in DR-CAT Raji cells and in human granulocytes. Carcinogenesis 1993;14:1573-8.
23. Singh S, Aggarwahl BB. Activation of transcription factor NF-KB is suppressed by curcumin (diferulolylmethane). J Biol Chem 1995;270:24995-5000.
24. Liu J-Y, Lin S-J, Lin J-K. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 1993;14:857-61.
25. Crompton CH, Cheung RY, Donjon C. I. Epstein-Barr virus surveillance after renal transplantation. Transplantation, 1994;57:1182-9.
26. Bunges D, Hardt C, Rollinghoff M, Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol 1981;11:657-61.
27. Maly F-E, Quilliam LA, Dorseuil O, et al. Activated or dominant inhibitory mutants of Rap1A decrease the oxidative burst of Epstein-Barr virus-transformed human B lymphocytes. J Biol Chem 1994;269:18743-6.
28. Kobayashi S, Imajoh-Ohmi S, Kuribayashi F. Characterization of the superoxide-generating system in human peripheral lymphocytes and lymphoid cell lines. J Biochem 1995;117:758-65.
29. Ruby AJ, Kuttan G, Dinesh Babu K, et al. Antitumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995;94: 79-83.
30. Baeuerle PA. The inducible transcription activator NF-KB: Regulation by distinct protein subunits. Biochim Biophys Acta 1991;1072:63-80.
31. Yamamoto R, Hinoma Y. Clonal transformation of human leukocytes by Epstein-Barr virus in soft agar. J. Cancer 1976;17:191-6.